» Articles » PMID: 22774983

Selective Localization of T Helper Subsets in Labial Salivary Glands from Primary Sjögren's Syndrome Patients

Overview
Date 2012 Jul 11
PMID 22774983
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to investigate the initiation and progression of autoimmune damage in the lesions of labial salivary glands (LSGs) from primary Sjögren's syndrome (SS) patients by examining the selective localization of T helper (Th) subsets such as Th1, Th2, Th17 regulatory T cells (T(regs)) and follicular T helper cells (Tfh). The expression of cytokines and transcription factors associated with these Th subsets in the LSGs from 54 SS patients and 16 healthy controls was examined using real-time polymerase chain reaction (PCR) and immunostaining. Additionally, infiltrating lymphocytes without germinal centre (GC(-)) and with GC (GC(+)) in the LSGs specimens from eight SS patients were extracted selectively by laser capture microdissection (LCM). The mRNA expression of these molecules was compared between the two sample groups of GC(-) and GC(+) by real-time PCR. The mRNA expression of cytokines and transcription factors of all T helper (Th) subsets in the LSGs from the SS patients was increased significantly in comparison with controls. In LSGs from the SS patients, Th2 and Tfh was associated closely with strong lymphocytic infiltration; however, Th1, Th17 and T(regs) was not. In the selectively extracted lesions of LSGs, Th1 and Th17-related molecules were detected strongly in the GC(-), while Th2 and Tfh-related molecules were detected in the GC(+). In contrast, no significant association with strong lymphocytic infiltration was observed in T(reg)-related molecules. These results indicate that SS has selective localization of Th subsets such as Th1, Th2, Th17 and Tfh in the LSGs, which is associated closely with disease severity and/or status. SS might be initiated by Th1 and Th17 cells, and then progressed by Th2 and Tfh cells via GC formation.

Citing Articles

Anti-SSA/SSB antibody double-negative Sjögren's disease patients: a comprehensive clinical study and immune profile.

Han Y, Wang R, Sun F, Feng R, Li H, Ning Y Clin Rheumatol. 2025; .

PMID: 39969675 DOI: 10.1007/s10067-024-07295-7.


Serum and tear autoantibodies from NOD and NOR mice as potential diagnostic indicators of local and systemic inflammation in Sjögren's disease.

Singh Kakan S, Abdelhamid S, Ju Y, MacKay J, Edman M, Raman I Front Immunol. 2025; 15:1516330.

PMID: 39936155 PMC: 11810956. DOI: 10.3389/fimmu.2024.1516330.


SHED-Derived Exosomes Ameliorate Sjögren's Syndrome-Induced Hyposalivation by Suppressing Th1 Cell Response via the miR-29a-3p/T-bet Axis.

Du Z, Chu W, Peng X, Wu L, Liu Y, Yu G ACS Appl Mater Interfaces. 2025; 17(4):5752-5761.

PMID: 39803988 PMC: 11788986. DOI: 10.1021/acsami.4c16595.


Tear cytokine levels in Sjogren's syndrome-related dry eye disease compared with non-Sjogren's syndrome-related dry eye disease patients: A meta-analysis.

Li J, Liu Y, Liu Z, Li X Medicine (Baltimore). 2024; 103(49):e40669.

PMID: 39654248 PMC: 11631033. DOI: 10.1097/MD.0000000000040669.


Subpopulation dynamics of T and B lymphocytes in Sjögren's syndrome: implications for disease activity and treatment.

Meng Q, Ma J, Cui J, Gu Y, Shan Y Front Immunol. 2024; 15:1468469.

PMID: 39290700 PMC: 11405198. DOI: 10.3389/fimmu.2024.1468469.


References
1.
Rapoport M, Jaramillo A, Zipris D, Lazarus A, Serreze D, Leiter E . Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med. 1993; 178(1):87-99. PMC: 2191073. DOI: 10.1084/jem.178.1.87. View

2.
Cederbom L, Hall H, Ivars F . CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol. 2000; 30(6):1538-43. DOI: 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X. View

3.
Ozaki K, Spolski R, Feng C, Qi C, Cheng J, Sher A . A critical role for IL-21 in regulating immunoglobulin production. Science. 2002; 298(5598):1630-4. DOI: 10.1126/science.1077002. View

4.
Price E, Venables P . The etiopathogenesis of Sjögren's syndrome. Semin Arthritis Rheum. 1995; 25(2):117-33. DOI: 10.1016/s0049-0172(95)80025-5. View

5.
Fox R . Sjögren's syndrome. Lancet. 2005; 366(9482):321-31. DOI: 10.1016/S0140-6736(05)66990-5. View